ANIK

Anika Therapeutics Inc. News Headlines

$42
*  
unch
unch
Get ANIK Alerts
*Delayed - data as of Sep. 2, 2014  -  Find a broker to begin trading ANIK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Anika Therapeutics: Profitable, Cheap And Overlooked
6/21/2013 4:27:00 PM - Seeking Alpha

DaVita and Myriad Join Forces - Analyst Blog
6/18/2013 6:25:01 PM - Zacks.com

Data on Astex Candidate - Analyst Blog
6/18/2013 4:32:13 PM - Zacks.com

Amgen Xgeva Label Expanded - Analyst Blog
6/17/2013 4:32:18 PM - Zacks.com

Myriad: End to Legal Battle over Patents - Analyst Blog
6/17/2013 2:30:39 PM - Zacks.com

Good News for Celgene's Revlimid - Analyst Blog
6/17/2013 11:31:15 AM - Zacks.com

CELG Presents Positive Long-term Data - Analyst Blog
6/13/2013 4:31:02 PM - Zacks.com

Dynavax Down on Heplisav Delay - Analyst Blog
6/11/2013 7:26:34 PM - Zacks.com

SGEN Starts Adcetris Phase I/II Study - Analyst Blog
6/11/2013 7:15:01 PM - Zacks.com

Xenon Licenses Isis Drug - Analyst Blog
6/11/2013 11:28:14 AM - Zacks.com

Encouraging Data on Alexion's Soliris - Analyst Blog
6/10/2013 12:10:01 PM - Zacks.com

Priority Review for Gilead Drug - Analyst Blog
6/10/2013 9:28:42 AM - Zacks.com

Astellas, Tecnofarma in Distribution Deal - Analyst Blog
6/6/2013 6:27:40 PM - Zacks.com

Encouraging Data on Isis Candidate - Analyst Blog
6/6/2013 11:27:36 AM - Zacks.com

FDA Issues Warning Letter to Novartis - Analyst Blog
6/5/2013 6:29:19 PM - Zacks.com

Setback for Pluristem Therapeutics - Analyst Blog
6/5/2013 5:27:36 PM - Zacks.com

The Medicines Co. Inks Deal with ProFibrix - Analyst Blog
6/5/2013 11:29:01 AM - Zacks.com

Canada Nod for Medivation's Xtandi - Analyst Blog
6/4/2013 11:27:25 AM - Zacks.com

Roche Presents Data on Avastin - Analyst Blog
6/3/2013 4:29:34 PM - Zacks.com

CHMP Positive on Teva's Lonquex - Analyst Blog
6/3/2013 4:26:01 PM - Zacks.com

Biogen Delays EU Launch of Tecfidera - Analyst Blog
5/31/2013 12:20:01 PM - Zacks.com

Medivation/Astellas Seek Xtandi Approval in Japan - Analyst Blog
5/29/2013 4:26:52 PM - Zacks.com

4 Cash Rich Small And Mid Caps Favored By Institutional Investors
5/29/2013 7:45:00 AM - Seeking Alpha

Promising Data on ONCY's Reolysin - Analyst Blog
5/24/2013 5:26:42 PM - Zacks.com

Encouraging News for Peregrine Pharma - Analyst Blog
5/24/2013 12:28:57 PM - Zacks.com